Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
PaperCitations, authors & open-access status
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 182 citations, 2015 year and hybrid oa status.
182
Citations
2015
Year
hybrid
OA Status